 The current pilot study will first demonstrate the safety and feasibility of converting maintenance transplant recipients to a once daily regimen, while measure of patient satisfaction and adherence are secondary outcomes. The purpose of this study is to determine the safety and feasibility of converting maintenance kidney transplant recipients i.e. those more than one year post transplantation to a once daily drug regimen including immunosuppressant and non-immunosuppressant drugs. We believe that conversion to a once daily O.D. medication regimen for both immunosuppressive and non-immunosuppressive medications will be associated with increased patient adherence and satisfaction. 